Close
  Indian J Med Microbiol
 

Figure 4: Bar plots showing 128 fatty acid levels in BAT. Levels of (a) Cer, (b) LPE, (c) PC, (d) PE, (e) SM in non-treated db/db mice (CS), treated with exercise (EC), liraglutide (LC), and both exercise and liraglutide (LE) groups. Data are expressed as the mean ± SD on a logarithmic scale. Difference between the groups were analyzed by two-way ANOVA (with post hoc analyses). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, compared to the CS or EC. Data are expressed as the mean ± SD on a logarithmic scale. LPE: Lyso PE, Cer: Ceramide, PC: Phosphatidylcholine, PE: Phosphatidylethanolamine, SM: Sphingomyelin, SD: Standard deviation, CS: Control group, EC: Exercise group, LC: Liraglutide group, LE: Liraglutide, and exercise group, BAT: Brown adipose tissue.

Figure 4: Bar plots showing 128 fatty acid levels in BAT. Levels of (a) Cer, (b) LPE, (c) PC, (d) PE, (e) SM in non-treated db/db mice (CS), treated with exercise (EC), liraglutide (LC), and both exercise and liraglutide (LE) groups. Data are expressed as the mean ± SD on a logarithmic scale. Difference between the groups were analyzed by two-way ANOVA (with <i>post hoc</i> analyses). *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, ****<i>P</i> < 0.0001, compared to the CS or EC. Data are expressed as the mean ± SD on a logarithmic scale. LPE: Lyso PE, Cer: Ceramide, PC: Phosphatidylcholine, PE: Phosphatidylethanolamine, SM: Sphingomyelin, SD: Standard deviation, CS: Control group, EC: Exercise group, LC: Liraglutide group, LE: Liraglutide, and exercise group, BAT: Brown adipose tissue.